首頁 › 大腸直腸癌 › 內布拉斯加

內布拉斯加的大腸直腸癌臨床試驗

22 項針對大腸直腸癌的研究正在內布拉斯加各地點尋找參與者。

內布拉斯加的城市

官方研究文本（英文）

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Nebraska Medicine-Bellevue, Bellevue
Nebraska Medicine-Village Pointe, Omaha
University of Nebraska Medical Center, Omaha

招募中2 期

18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

CHI Health Saint Francis, Grand Island
CHI Health Good Samaritan, Kearney
Alegent Health Immanuel Medical Center, Omaha
還有 2 項

招募中觀察性研究歡迎健康志工

40 至 75 歲 · 所有性別 · 更新於 2026年10月2日 · NCT05334069

Family Communications After Genetic Testing

CHI Health Saint Francis, Grand Island
CHI Health Good Samaritan, Kearney
Alegent Health Immanuel Medical Center, Omaha
還有 2 項

招募中歡迎健康志工

18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT07143487

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #2, Omaha

招募中1 期

18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT05176483

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Nebraska Cancer Specialists, Omaha
XCancer, Omaha

招募中1/2 期

18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT07189871

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646, Omaha

招募中2 期

18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT06820463

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Cancer Partners of Nebraska, Lincoln

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07222800

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Nebraska Cancer Specialists, Omaha

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Nebraska Cancer Specialists Midwest Cancer Center, Omaha

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06662786

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

University Of Nebraska Medical Center, Omaha

招募中2/3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月23日 · NCT07221357

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Nebraska Cancer Specialists, Omaha
University of Nebraska Medical Center, Omaha

招募中1/2 期

18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT06445062

Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island, Grand Island
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Regional, Grand Island
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Methodist, Omaha
還有 3 項

招募中3 期

18 歲及以上 · 所有性別 · 更新於 2026年9月21日 · NCT07750158